More Investment By Pharmaceutical Companies Needed To Fight Antimicrobial Resistance, Experts Say
November 11, 2021
MedPage Today (11/10, Basen) reports, “Large pharmaceutical companies, investors, and other funders must increase investments to address antimicrobial resistance (AMR), and must do so now, experts and industry insiders said here this week.” Many public he...